Mechanisms underlying the structural alterations of the rat submandibular gland induced by Tityus serrulatus tityustoxin.
As the mechanisms underlying the structural changes induced in rat submandibular glands by Tityus serrulatus tityustoxin have not been reported, the present study was undertaken to investigate the participation of adrenergic and muscarinic cholinergic receptors in these alterations. Most of the stimulatory effects of the toxin are observed in the secretory cells of the acini and granular convoluted tubules (GCT). We evaluated the ability of the toxin to induce morphological changes in acinar and GCT cells after adrenoreceptor and cholino receptor blockage. The influence of tityustoxin-induced adrenal discharge on the acinar and GCT cells was also investigated after bilateral adrenalectomy. We show that the intense cytoplasmic vacuolation of the acinar cells induced by tityustoxin was prevented by prazosin (alpha(1) adenoreceptor blockade) and atropine (muscarinic cholinoreceptor blockade). The decrease of GCT cell granules following tityustoxin injection was completely blocked by prasozin and partially by propranolol. These results indicate that acinar vacuolation, degranulation of GCT cells, reduction of GCT diameter and height of its epithelium depends on tityustoxin induced adrenergic and cholinergic mechanisms. In contrast, tityustoxin induced acinar cell degranulation was not modified by atropine, prasozin or propranolol (beta(1)-beta(2) adenoreceptor blockade). Thus, acinar degranulation seems to be due to a direct action of tityustoxin on of the rat submandibular glands. The degranulation of the GCT cells and the acinar vacuolation was also prevented by bilateral adrenalectomy, suggesting that these effects are mostly due to catecholamines released from the adrenal glands.
Clemente
G T
GT
Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, P.O. Box 486, 30161-970 Belo Horizonte MG, Brazil.
Teixeira
M M
MM
Freire-Maia
L
L
Rossoni
R B
RB
D000315:Adrenalectomy; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D015550:Cell Degranulation / Q000187:drug effects; D004336:Drug Antagonism; D008297:Male; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009498:Neurotoxins / Q000633:toxicity*; D011224:Prazosin / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012604:Scorpion Venoms / Q000633:toxicity*; D012605:Scorpions; D013363:Submandibular Gland / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D014617:Vacuoles / Q000187:drug effects / Q000473:pathology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D018727:Muscarinic Antagonists; D009498:Neurotoxins; D012604:Scorpion Venoms; C003609:tityustoxin; D001285:Atropine; D011433:Propranolol; D011224:Prazosin